吉林長龍藥業：二零一八年度業績公告.pdf

1、香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公佈全部或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。吉林省輝南長龍生化藥業股份有限公司Jilin Province Huinan Changlong Bio-pharmacy Company Limited（於中華人民共和國註冊成立之股份有限公司）（股份代號：8049）二零一八年度業績公告吉林省輝南長龍生化藥業股份有限公司（本公司）之董事會（董事會）欣然宣佈，本公司及其附屬公司截至二零一八年十二月三十一日止年度之經審核業績。本公告載列本公司二零一

2、八年年報全文，乃符合香港聯合交易所有限公司（聯交所）GEM證券上市規則（GEM上市規則）有關年度業績初步公告附載之資料之相關規定。承董事會命吉林省輝南長龍生化藥業股份有限公司主席張弘中國吉林省，二零一九年三月二十九日 1 於本公佈日期，本公司董事會成員包括六名執行董事張弘、張曉光、趙寶剛、吳國文、張翼及徐向夫；以及三名獨立非執行董事高永才、高其品及田傑。本公佈（吉林省輝南長龍生化藥業股份有限公司各董事願共同及個別對此負全責）乃遵照香港聯合交易所有限公司 GEM證券上市規則 之規定而提供有關吉林省輝南長龍生化藥業股份有限公司之資料。各董事經作出一切合理查詢後，確認就彼等所知及所信：(1)本公佈所

3、載資料在各重大方面均屬準確及完整，且無誤導成份；(2)並無遺漏任何其他事實致使本公佈所載任何內容產生誤導；及(3)本公佈內表達的一切意見乃經審慎周詳的考慮後方作出，並以公平合理的基準和假設為依據。本公佈將由其刊載日期起計至少七天於GEM網站最新公司公告 一欄刊登。2 CHARACTERISTICS OF THE GEM OF THE STOCK EXCHANGE OF HONG KONG LIMITED(THE“STOCK EXCHANGE”)GEM has been positioned as a market designed to accommodate small and mid-si

4、zed companies to which a higher investment risk may be attached than other companies listed on the main board of the Stock Exchange.Prospective investors should be aware of the potential risks of investing in such companies and should make the decision to invest only after due and careful considerat

5、ion.Given that the companies listed on the GEM are generally small and midsized companies,there is a risk that securities traded on the GEM may be more susceptible to high market volatility than securities traded on the Main Board of the Stock Exchange and no assurance is given that there will be a

6、liquid market in the securities traded on the GEM.Hong Kong Exchanges and Clearing Limited and the Stock Exchange take no responsibility for the contents of this report,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever ar